These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 11073979)

  • 1. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.
    Lee KS; Kim HJ; Li QL; Chi XZ; Ueta C; Komori T; Wozney JM; Kim EG; Choi JY; Ryoo HM; Bae SC
    Mol Cell Biol; 2000 Dec; 20(23):8783-92. PubMed ID: 11073979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5.
    Nishimura R; Hata K; Harris SE; Ikeda F; Yoneda T
    Bone; 2002 Aug; 31(2):303-12. PubMed ID: 12151083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intimate relationship between TGF-beta/BMP signaling and runt domain transcription factor, PEBP2/CBF.
    Bae SC; Lee KS; Zhang YW; Ito Y
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S48-55. PubMed ID: 11263665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein.
    Lee KS; Hong SH; Bae SC
    Oncogene; 2002 Oct; 21(47):7156-63. PubMed ID: 12370805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts.
    Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T
    Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bone morphogenetic protein-2 and transforming growth factor beta1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells.
    Takagi M; Kamiya N; Takahashi T; Ito S; Hasegawa M; Suzuki N; Nakanishi K
    J Mol Histol; 2004 Jan; 35(1):81-90. PubMed ID: 15323353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
    Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
    J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
    Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
    J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
    Gu K; Zhang L; Jin T; Rutherford RB
    Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12.
    Nishimura R; Kato Y; Chen D; Harris SE; Mundy GR; Yoneda T
    J Biol Chem; 1998 Jan; 273(4):1872-9. PubMed ID: 9442019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of the Ski-interacting protein (SKIP) on differentiation induced by transforming growth factor-beta1 and bone morphogenetic protein-2 in C2C12 cells.
    Figueroa JD; Hayman MJ
    Exp Cell Res; 2004 Jun; 296(2):163-72. PubMed ID: 15149847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression.
    Lee MH; Kim YJ; Kim HJ; Park HD; Kang AR; Kyung HM; Sung JH; Wozney JM; Kim HJ; Ryoo HM
    J Biol Chem; 2003 Sep; 278(36):34387-94. PubMed ID: 12815054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation.
    Spinella-Jaegle S; Roman-Roman S; Faucheu C; Dunn FW; Kawai S; Galléa S; Stiot V; Blanchet AM; Courtois B; Baron R; Rawadi G
    Bone; 2001 Oct; 29(4):323-30. PubMed ID: 11595614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage.
    Sowa H; Kaji H; Canaff L; Hendy GN; Tsukamoto T; Yamaguchi T; Miyazono K; Sugimoto T; Chihara K
    J Biol Chem; 2003 Jun; 278(23):21058-69. PubMed ID: 12649288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation.
    Ying SX; Hussain ZJ; Zhang YE
    J Biol Chem; 2003 Oct; 278(40):39029-36. PubMed ID: 12871975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription.
    Afzal F; Pratap J; Ito K; Ito Y; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Javed A
    J Cell Physiol; 2005 Jul; 204(1):63-72. PubMed ID: 15573378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7.
    Tou L; Quibria N; Alexander JM
    Mol Cell Endocrinol; 2003 Jul; 205(1-2):121-9. PubMed ID: 12890574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).
    Pardali K; Kowanetz M; Heldin CH; Moustakas A
    J Cell Physiol; 2005 Jul; 204(1):260-72. PubMed ID: 15690394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
    Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
    Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway.
    Haÿ E; Lemonnier J; Fromigué O; Marie PJ
    J Biol Chem; 2001 Aug; 276(31):29028-36. PubMed ID: 11395480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.